Disease Activity

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis
Jean W Liew, Irvin J Huang, Diana N Louden, Namrata Singh, Lianne S Gensler

RMD Open May 2020, 6 (1) e001225; DOI: 10.1136/rmdopen-2020-001225
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
Ennio Lubrano, Silvia Scriffignano, Ana Belen Azuaga, Julio Ramirez, Juan D Cañete, Fabio Massimo Perrotta

RMD Open Mar 2020, 6 (1) e001170; DOI: 10.1136/rmdopen-2020-001170
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
Jose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, Fernando Pimentel-Santos, Ana Filipa Mourão, Nélia Gouveia, Jaime Cunha Branco, Helena Santos, Elsa Vieira-Sousa, Filipe Vinagre, João Tavares-Costa, João Rovisco, Miguel Bernardes, Nathalie Madeira, Rita Cruz-Machado, Raquel Roque, Joana Leite Silva, Mary Lucy Marques, Raquel Miriam Ferreira, Sofia Ramiro

RMD Open Jan 2020, 6 (1) e001145; DOI: 10.1136/rmdopen-2019-001145
Prognosis of pneumonia in patients with rheumatoid arthritis: the role of medication and disease activity prior to admission a population-based cohort study
Mette Holland-Fischer, Reimar W Thomsen, Ulrik Tarp, Mette Nørgaard

RMD Open Feb 2020, 6 (1) e001102; DOI: 10.1136/rmdopen-2019-001102
Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
Bin Huang, Tingting Qiu, Chen Chen, Yin Zhang, Michael Seid, Dan Lovell, Hermine I Brunner, Esi M Morgan

RMD Open Jan 2020, 6 (1) e001091; DOI: 10.1136/rmdopen-2019-001091
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study
Alain Saraux, René-Marc Flipo, Francis Fagnani, Jacques Massol, Gabrielle Cukierman, Jean-Michel Joubert, Philippe Huot-Marchand, Bernard Combe

RMD Open Jan 2020, 6 (1) e000991; DOI: 10.1136/rmdopen-2019-000991
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice
Niels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, Rob Janknegt, Ralph Peeters, Robert B M Landewé

RMD Open Nov 2019, 5 (2) e001050; DOI: 10.1136/rmdopen-2019-001050
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
Gerd R Burmester, Vibeke Strand, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Gregory St John, Susan Boklage, Mark C Genovese

RMD Open Oct 2019, 5 (2) e001017; DOI: 10.1136/rmdopen-2019-001017
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
Denis Mongin, Kim Lauper, Carl Turesson, Merete Lund Hetland, Eirik Klami Kristianslund, Tore K Kvien, Maria Jose Santos, Karel Pavelka, Florenzo Iannone, Axel Finckh, Delphine Sophie Courvoisier

RMD Open Oct 2019, 5 (2) e000994; DOI: 10.1136/rmdopen-2019-000994
Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry
Sytske Anne Bergstra, Maura C Couto, Nimmisha Govind, Arvind Chopra, Karen Salomon Escoto, Elizabeth Murphy, Tom WJ Huizinga, Cornelia F Allaart

RMD Open Jul 2019, 5 (2) e000969; DOI: 10.1136/rmdopen-2019-000969

Main menu

Disease Activity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Disease Activity

Pages